Position in VRTX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$10,673,645
-$5,620,113 QoQ
Shares Held
23,903
-33.5% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Andra AP-fonden holds $89,889,169 across 7 Biotechnology names. VRTX ranks #4 (11.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
86,697 | $28,685,436 | |
| 2 | INCY |
Incyte Corp
|
259,048 | $24,381,597 | |
| 3 | INSM |
INSMED Inc
|
77,970 | $12,749,654 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
23,903 | $10,673,645 | |
| 5 | RPRX |
Royalty Pharma plc
|
177,500 | $8,514,675 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,232 | $3,269,812 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
16,600 | $1,614,350 |
All Filings in VRTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,673,645 | 23,903 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $16,293,758 | 35,940 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $14,059,876 | 35,900 | Shares | Sole | 2025-11-12 | |
| 2025-03-31 | $2,666,510 | 5,500 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $14,537,470 | 36,100 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $19,347,328 | 41,600 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $32,716,656 | 69,800 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $34,193,218 | 81,800 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $9,358,470 | 23,000 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $5,981,128 | 17,200 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $6,334,380 | 18,000 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $10,901,422 | 34,600 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $12,706,320 | 44,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $16,503,780 | 57,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $17,780,949 | 63,100 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $16,601,760 | 75,600 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $12,969,385 | 71,500 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $13,872,144 | 68,800 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $9,949,407 | 46,300 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $12,124,242 | 51,300 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $8,299,660 | 30,500 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $8,796,393 | 30,300 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $5,734,595 | 24,100 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||